Beijing Health (Holdings) (HKSE:02389) Other Financing: HK$-66.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beijing Health (Holdings) Other Financing?

Beijing Health (Holdings) HKSE:02389 Other Financing is HK$-66.9 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Beijing Health (Holdings)'s Other Financing for the six months ended in Dec. 2025 was HK$-69.0 Mil.

Beijing Health (Holdings)'s Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-66.9 Mil.

Beijing Health (Holdings) Other Financing Historical Data

* Premium members only.

The historical data trend for Beijing Health (Holdings)'s Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Health (Holdings) Other Financing Chart

Beijing Health (Holdings) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.30 -3.36 -36.62 -1.63 16.90

Beijing Health (Holdings) Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 -0.78 2.14 -68.99 0.00

Beijing Health (Holdings) Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-66.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$-66.9 Mil mean?
Beijing Health (Holdings) (HKSE:02389) has a Other Financing of HK$-66.9 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Beijing Health (Holdings) and its competitors.
Is Beijing Health (Holdings)'s Other Financing too high?
Beijing Health (Holdings)'s current Other Financing is HK$-66.9 Mil.
How does Beijing Health (Holdings)'s Other Financing compare to HCA and THC?
Beijing Health (Holdings)'s Other Financing of HK$-66.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Beijing Health (Holdings) and its competitors. Beijing Health (Holdings)'s current Other Financing is HK$-66.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health (Holdings) stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health (Holdings) (HKSE:02389) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.08 — trading 1.3% above its estimated fair value. The current Other Financing is HK$-66.9 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Beijing Health (Holdings) (HKSE:02389), the current Other Financing is HK$-66.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beijing Health (Holdings) Business Description

Address 909 Cheung Sha Wan Road, Unit 2704, 27th Floor, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Beijing Health (Holdings) Ltd is involved in the provision of medical care, health care, and geriatric care-related services and products in the People's Republic of China (the PRC). It has a single operating and reportable segment, which is the provision of medical care, health care and geriatric care-related services and products. Geographically, it operates and derives revenue from Mainland China.